UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002654
Receipt number R000003232
Scientific Title A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamine
Date of disclosure of the study information 2009/10/26
Last modified on 2012/01/14 18:13:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamine

Acronym

Efficacy of sertraline for SSRI non-remitted or intolerant cases

Scientific Title

A study of efficacy and safety of sertraline for the treatment of major depressive disorder patients, who have benn unremitted or intolerant by paroxetine or fluvoxamine

Scientific Title:Acronym

Efficacy of sertraline for SSRI non-remitted or intolerant cases

Region

Japan


Condition

Condition

major depressive disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine a efficacy and safety of a switch to sertraline in major depresive patients, who have been unremitted or intolerant by paroxetine or fluvoxamine.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

remission rate by QIDS-SRJ

Key secondary outcomes

response rate by QIDS-SRJ
response rate by HAMD
remission rate by HAMD
reduction in QIDS-SRJ scores


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Switching from prior SSRI (fluvoxamine or paroxetine) to sertraline

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1. Written informed consent by patients
2. more than 19 years old, less than 70 years old
3. Major depessive diorder by DSM-IVTR
4. unremitted or intorelant patients by paroxetine or fluvoxamine

Key exclusion criteria

1. severe physical diseases (heart, liver, kidney)
2. significant risk of suicide
3. under treatment with cognitvie-behavioral therapy of ECT
4. pregnant or breast-feeding women or women, who may be pregnant
5. organic brain disease
6. patients, whom investigaters regard as inapporopriate for subjects

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Inoue

Organization

Hokkaido University Hospital

Division name

Psychiatry

Zip code


Address

Kita 14, Nishi 5, Kita-ku, Sapporo

TEL

011-716-1161

Email



Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Inoue

Organization

Hokkaido University Hospital

Division name

Psychiatry

Zip code


Address

Kita 14, Nishi 5, Kita-ku, Sapporo

TEL

011-716-1161

Homepage URL


Email

tinoue@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital, Department of Psychiatry

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University Hospital, Department of Psychiatry

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)、札幌花園病院(北海道)、本田病院(北海道)、札幌鈴木病院(北海道)、石金病院(北海道)、町立八雲総合病院(北海道)、川村メンタルクリニック(北海道)、苫小牧緑ヶ丘病院(北海道)


Other administrative information

Date of disclosure of the study information

2009 Year 10 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2008 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 09 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry

2011 Year 09 Month 01 Day

Date trial data considered complete

2011 Year 09 Month 01 Day

Date analysis concluded

2011 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 10 Month 21 Day

Last modified on

2012 Year 01 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003232


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name